article thumbnail

Omnicell Unveils Groundbreaking Robotic Compounding Technology in Winter 2022 Release

Omnicell

Dennis Wright Senior Director, Product Marketing, Omnicell For more than 15 years, IV robotics has proven efficacy in safe and efficient sterile compounding, but market adoption has been limited. Our engineering team scoured through design ideas and broke down all the compounded activities into individual tasks.

article thumbnail

Leveraging Sterile Compounding Technology and Removing Barriers to Improve Safety

Omnicell

And one of the highest areas of opportunity for human error is in the sterile compounding process. The guidelines recognize IV workflow management systems as the minimum safety standard for preparing compounded preparations and IV robotics are recommended for high volume, large batch preparations.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Elevating Sterile Compounding Accuracy

Omnicell

Terri Albarano, PharmD Director, Autonomous Pharmacy, Omnicell Sterile compounding safety is one of the biggest challenges for the pharmacy supply chain. Health systems are expected to compound IV preparations with increasingly complex regulations, rising drug costs, and supply disruptions. Injectable medications cause 1.2

article thumbnail

Adopting Automation Supports Safer, More Efficient Sterile Compounding

Omnicell

Dennis Wright Senior Director, Central Pharmacy Dispensing Services, Omnicell As disruption and uncertainty in the supply of IV medications from outsourced compounding facilities continues, health system pharmacies should reevaluate how they are managing sterile compounding needs. 23 at 1 pm ET.

article thumbnail

Welcome to Opening Day of Omnicell Illuminate 2020

Omnicell

Randall Lipps Chairman, President, CEO, and Founder, Omnicell Today, I was excited to join thousands of registrants representing pharmacy, nursing, informatics, and healthcare leaders for the launch of Omnicell Illuminate 2020 , one of the year’s biggest digital events dedicated to technology-driven medication management.

article thumbnail

Why IV Automation Is Critical for Sterile Compounding

Omnicell

Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell Imagine if Amazon lost one out of every 10 packages. So why, as clinicians, are we not focused on improving the documented one in 10 inaccuracies in sterile compounded products? Or the airlines lost 10% of passenger bags.

article thumbnail

Driving Safety and Savings Through System-Wide Sterile Compounding Automation

Omnicell

David Webster Director of Acute Care Pharmacy Operations, University of Rochester Medical Center Sterile compounding is one of the most high risk, high cost areas of medication management. Manual compounding is fraught with error, studies indicating 1 in 10 IVs are not prepared according to guidelines.